Cellular Senescence and White-Matter Injury: A Proposed Glial Cascade in AD and Cerebral SVD
Aging and Disease · 2026
DOI: 10.14336/ad.2026.1063 ↗Abstract
Cellular senescence is one of the hallmarks of aging and has been implicated in age-related neurological disorders, including Alzheimer's disease (AD) and cerebral small-vessel disease (SVD). AD and SVD frequently coexist and both become more common with age, so an age-dependent mechanism may contribute to both. Although their upstream pathologies differ, both can damage white matter. This review proposes a cascade in which microglial senescence may sustain inflammation in white matter and impair myelin debris clearance. In this environment, oligodendrocyte precursor cells (OPCs) may differentiate poorly, limiting remyelination, while senescence-like changes within these cells may compound this deficit. Senescent brain endothelial cells may also damage white matter through blood-brain barrier disruption, microvascular rarefaction, reduced perfusion, and impaired neurovascular coupling. Because barrier leakage activates microglia and poor perfusion may limit metabolic support to the oligodendrocyte lineage, these vascular changes could aggravate glial dysfunction. This review integrates evidence scattered across different models and diseases, examining each link in the proposed cascade in turn. The full sequence has not yet been demonstrated in a single experimental system or in humans. In animal models, eliminating or modulating senescent cells has improved pathology or cognition, and restoring aged OPC function has enhanced remyelination. In people, senolytic trials have assessed safety and drug exposure but have not yet established clinical benefit. White-matter injury may serve as a measurable endpoint shared by AD and SVD, and cellular senescence remains a potential contributor to this injury.
EUVIMED